Gardasil® 9

GARDASIL 9 is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases:

  • Cervical, vulvar, vaginal, and anal cancer caused by Human Papillomavirus (HPV) types 16, 18, 31, 33, 45, 52, and 58.
  • Genital warts (condyloma acuminata) caused by HPV types 6 and 11.

And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

  • Cervical intraepithelial neoplasia (CIN) grade 2/3 and cervical adenocarcinoma in situ (AIS).
  • Cervical intraepithelial neoplasia (CIN) grade 1.
  • Vulvar intraepithelial neoplasia (VIN) grade 2 and grade 3.
  • Vaginal intraepithelial neoplasia (VaIN) grade 2 and grade 3.
  • Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3.

GARDASIL 9 is indicated in boys and men 9 through 26 years of age for the prevention of the following diseases:

  • Anal cancer caused by HPV types 16, 18, 31, 33, 45, 52, and 58.
  • Genital warts (condyloma acuminata) caused by HPV types 6 and 11.

And the following precancerous or dysplastic lesions caused by HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58:

  • Anal intraepithelial neoplasia (AIN) grades 1, 2, and 3.

For indications, dosing and other information, please refer to the prescribing information.

Gardasil® 9 ‐ Merck

Size:
10 pack, 0.5 mL single-dose vials
NDC #:
00006-4119-03
Download:
PI
Size:
10 pack, 0.5 mL single-dose prefilled Luer Lock syringes with tip caps
NDC #:
00006-4121-02
Download:
PI